Distribution of Candida species among bloodstream isolates
- PMID: 15138521
Distribution of Candida species among bloodstream isolates
Abstract
Objective: To identify the distribution of Candida species causing bloodstream infections.
Methods: This study was conducted at the Armed Forces Hospital, Riyadh, Kingdom of Saudi Arabia. All cases of candidemia from the period 1996 through to 2002 were retrospectively identified through the records from the Department of Clinical Microbiology.
Results: Two hundred and ninety-four candidemic episodes were identified, 176 (59.9%) occurred in the intensive care units (ICUs), 32 (10.9%) medical, 30 (10.2%) surgical wards, 24 (8%) from patients with hematologic malignancies and 15 (5%) from pediatric wards. Candida albicans (C. albicans) was the most frequently isolated species with 149 (50.7%) cases, followed by Candida tropicalis (C. tropicalis) 61 (20.7%), Candida parapsilosis 32 (10.9%), Candida krusei (C. krusei) 23 (7.8%) and Candida glabrata 21 (7.1%). Other species were not common. There is an increase in the proportion of non C. albicans species as the causative agents of candidemia. In certain clinical settings, non C. albicans species predominate as in the Adult General Intensive Care Unit with C. tropicalis as the most common. While in patients with hematologic malignancies, C. krusei species is the most common.
Conclusion: These findings reinforce the need for continued and active surveillance programs to address the changes in the species distribution among candidal bloodstream isolates which will help to develop effective, preventive and therapeutic strategies.
Similar articles
-
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.Crit Care Med. 2007 Apr;35(4):1077-83. doi: 10.1097/01.CCM.0000259379.97694.00. Crit Care Med. 2007. PMID: 17312565
-
Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.Anesth Analg. 2008 Feb;106(2):523-9, table of contents. doi: 10.1213/ane.0b013e3181607262. Anesth Analg. 2008. PMID: 18227310
-
Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections.Clin Infect Dis. 2008 Jul 15;47(2):e17-24. doi: 10.1086/589298. Clin Infect Dis. 2008. PMID: 18549311
-
Epidemiology of candidaemia and invasive candidiasis. A changing face.Rev Iberoam Micol. 2014 Jan-Mar;31(1):42-8. doi: 10.1016/j.riam.2013.10.001. Epub 2013 Nov 19. Rev Iberoam Micol. 2014. PMID: 24270071 Review.
-
Candida albicans or Candida dubliniensis?Mycoses. 2011 Jan;54(1):1-16. doi: 10.1111/j.1439-0507.2009.01759.x. Mycoses. 2011. PMID: 19682314 Review.
Cited by
-
Antifungal resistance in patients with Candidaemia: a retrospective cohort study.BMC Infect Dis. 2020 Jan 17;20(1):55. doi: 10.1186/s12879-019-4710-z. BMC Infect Dis. 2020. PMID: 31952505 Free PMC article.
-
Prevalence and Species Distribution of Neonatal Candidiasis: A Systematic Review and Meta-Analysis.Diseases. 2024 Jul 12;12(7):154. doi: 10.3390/diseases12070154. Diseases. 2024. PMID: 39057125 Free PMC article. Review.
-
Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.J Clin Microbiol. 2006 Aug;44(8):2816-23. doi: 10.1128/JCM.00773-06. J Clin Microbiol. 2006. PMID: 16891497 Free PMC article.
-
Clinical and Microbiological Characteristics of Candidemia Cases in Saudi Arabia.Infect Drug Resist. 2023 Jul 10;16:4489-4503. doi: 10.2147/IDR.S411865. eCollection 2023. Infect Drug Resist. 2023. PMID: 37457797 Free PMC article.
-
Candidaemia in patients with haematological disorders and stem cell transplant.Libyan J Med. 2006 Nov 21;1(2):140-55. doi: 10.4176/061116. Libyan J Med. 2006. PMID: 21526012 Free PMC article.
MeSH terms
LinkOut - more resources
Medical